Showing results (61-70 of 481) with videos related to
Sort By:
Pageof 49
Journal of the American College of Cardiology|February 18, 2014
Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36)Ryan G O'Malley, Marc P Bonaca, Benjamin M Scirica, et al.JAMA|September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysisMichael G Silverman, Brian A Ference, Kyungah Im, et al.Journal of the American Heart Association|April 12, 2021
Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36Thomas A Zelniker, David A Morrow, Benjamin M Scirica, et al.Journal of the American College of Cardiology|October 8, 2021
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-ITKazuma Oyama, Robert P Giugliano, Michael A Blazing, et al.The American Journal of Cardiology|April 21, 2010
Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trialDov Shiffman, Marc S Sabatine, Judy Z Louie, et al.American Heart Journal|April 29, 2008
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor useMarc S Sabatine, Hussam N Hamdalla, Shamir R Mehta, et al.European Journal of Preventive Cardiology|February 24, 2021
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndromeBaris Gencer, David A Morrow, Eugene Braunwald, et al.Molecular & Cellular Proteomics : MCP|July 15, 2009
Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilutionHasmik Keshishian, Terri Addona, Michael Burgess, et al.Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.Clinical Chemistry|April 18, 2009
Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometryEric Kuhn, Terri Addona, Hasmik Keshishian, et al.Pageof 49